JP2006516195A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516195A5 JP2006516195A5 JP2006500864A JP2006500864A JP2006516195A5 JP 2006516195 A5 JP2006516195 A5 JP 2006516195A5 JP 2006500864 A JP2006500864 A JP 2006500864A JP 2006500864 A JP2006500864 A JP 2006500864A JP 2006516195 A5 JP2006516195 A5 JP 2006516195A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- vector
- bacterial
- mammalian
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 31
- 230000001580 bacterial effect Effects 0.000 claims 28
- 229920001184 polypeptide Polymers 0.000 claims 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims 15
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 12
- 239000000427 antigen Substances 0.000 claims 11
- 102000036639 antigens Human genes 0.000 claims 11
- 108091007433 antigens Proteins 0.000 claims 11
- 230000027455 binding Effects 0.000 claims 10
- 210000004962 mammalian cell Anatomy 0.000 claims 10
- 239000002773 nucleotide Substances 0.000 claims 9
- 125000003729 nucleotide group Chemical group 0.000 claims 9
- 108090000623 proteins and genes Proteins 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 7
- 230000004927 fusion Effects 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 241000588724 Escherichia coli Species 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 230000028327 secretion Effects 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 108091026890 Coding region Proteins 0.000 claims 2
- 108020004705 Codon Proteins 0.000 claims 2
- 108091006020 Fc-tagged proteins Proteins 0.000 claims 2
- 241000724791 Filamentous phage Species 0.000 claims 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 claims 2
- 108020005091 Replication Origin Proteins 0.000 claims 2
- 210000001322 periplasm Anatomy 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- DLZKEQQWXODGGZ-KCJUWKMLSA-N 2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DLZKEQQWXODGGZ-KCJUWKMLSA-N 0.000 claims 1
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 claims 1
- 101100136076 Aspergillus oryzae (strain ATCC 42149 / RIB 40) pel1 gene Proteins 0.000 claims 1
- 108010001857 Cell Surface Receptors Proteins 0.000 claims 1
- 230000004568 DNA-binding Effects 0.000 claims 1
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 claims 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 claims 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 1
- 241001529936 Murinae Species 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 108091023040 Transcription factor Proteins 0.000 claims 1
- 102000040945 Transcription factor Human genes 0.000 claims 1
- 239000007801 affinity label Substances 0.000 claims 1
- 210000004102 animal cell Anatomy 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 102000006240 membrane receptors Human genes 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 108700026679 orbivirus VP7 Proteins 0.000 claims 1
- 101150040383 pel2 gene Proteins 0.000 claims 1
- 101150050446 pelB gene Proteins 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 229920002704 polyhistidine Polymers 0.000 claims 1
- 230000004850 protein–protein interaction Effects 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43949203P | 2003-01-09 | 2003-01-09 | |
| US60/439,492 | 2003-01-09 | ||
| PCT/US2004/000462 WO2004063343A2 (en) | 2003-01-09 | 2004-01-08 | Dual expression vector system for antibody expression in bacterial and mammalian cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006516195A JP2006516195A (ja) | 2006-06-29 |
| JP2006516195A5 true JP2006516195A5 (https=) | 2007-02-22 |
| JP4773947B2 JP4773947B2 (ja) | 2011-09-14 |
Family
ID=32713489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006500864A Expired - Fee Related JP4773947B2 (ja) | 2003-01-09 | 2004-01-08 | 細菌細胞及び哺乳動物細胞における抗体発現のための二重発現ベクター系 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7112439B2 (https=) |
| EP (1) | EP1588166A4 (https=) |
| JP (1) | JP4773947B2 (https=) |
| AU (1) | AU2004204462B2 (https=) |
| BR (1) | BRPI0406662A (https=) |
| CA (1) | CA2513025A1 (https=) |
| IL (1) | IL169604A (https=) |
| WO (1) | WO2004063343A2 (https=) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1495055T3 (da) * | 2002-04-18 | 2013-11-11 | Genencor Int | Produktion af funktionelle antistoffer i filamentøse svampe |
| US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
| EP1588166A4 (en) * | 2003-01-09 | 2007-06-27 | Macrogenics Inc | VECTOR SYSTEM WITH DOUBLE EXPRESSION FOR EXPRESSING ANTIBODIES IN BACTERIAL AND MAMMAL CELLS |
| WO2006028480A1 (en) * | 2004-09-07 | 2006-03-16 | Clonex Development, Inc. | Cell lines for use in increasing protein yield form a cell culture |
| ATE466090T1 (de) * | 2004-12-07 | 2010-05-15 | Lonza Ag | Rhamnosepromotor-expressionssystem |
| WO2006122822A2 (en) | 2005-05-20 | 2006-11-23 | Lonza Biologics Plc. | High-level expression of recombinant antibody in a mammalian host cell |
| ES2385679T3 (es) * | 2006-08-24 | 2012-07-30 | Virovek, Inc. | Expresión de células de insecto de genes con marcos de lectura abiertos superpuestos, métodos y composiciones de éstos |
| US7745148B2 (en) | 2006-10-30 | 2010-06-29 | Functional Genetics, Inc. | Random homozygous gene perturbation to enhance antibody production |
| AU2009258063B2 (en) | 2007-06-21 | 2014-09-25 | Macrogenics, Inc. | BCR-complex-specific antibodies and methods of using same |
| US12529164B2 (en) | 2007-09-14 | 2026-01-20 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| US8691730B2 (en) | 2007-09-14 | 2014-04-08 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| US20110033476A1 (en) * | 2007-11-12 | 2011-02-10 | Theraclone Sciences Inc. | Compositions and methods for the therapy and diagnosis of influenza |
| NZ585500A (en) | 2007-11-12 | 2012-06-29 | Theraclone Sciences Inc | Antibodies which bind to an epitope in the extracellular domain of the matrix 2 ectodomain polypeptide of an influenza virus |
| US20090162845A1 (en) | 2007-12-20 | 2009-06-25 | Elazar Rabbani | Affinity tag nucleic acid and protein compositions, and processes for using same |
| CN107325182A (zh) | 2008-04-02 | 2017-11-07 | 宏观基因有限公司 | HER2/neu‑特异性抗体和其使用方法 |
| ES2675730T3 (es) | 2008-06-04 | 2018-07-12 | Macrogenics, Inc. | Anticuerpos con unión alterada a FcRn y métodos de uso de los mismos |
| US8546307B2 (en) * | 2008-10-03 | 2013-10-01 | Xoma Technology, Ltd. | Triple tag sequence and methods of use thereof |
| US9238878B2 (en) | 2009-02-17 | 2016-01-19 | Redwood Bioscience, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
| SI3260136T1 (sl) | 2009-03-17 | 2021-05-31 | Theraclone Sciences, Inc. | Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa |
| CN102459340A (zh) * | 2009-04-23 | 2012-05-16 | 特罗科隆科学有限公司 | 粒性白血细胞-巨噬细胞菌落-刺激因子(gm-csf)中和抗体 |
| JP2012527473A (ja) | 2009-05-20 | 2012-11-08 | セラクローン サイエンシーズ， インコーポレイテッド | インフルエンザの治療および診断のための組成物および方法 |
| EP2445539A4 (en) * | 2009-06-26 | 2015-05-20 | Five Prime Therapeutics Inc | VALIDATION OF TARGETS OF THERAPEUTIC ANTIBODIES AND IN VIVO SCREENING |
| WO2012021786A2 (en) | 2010-08-12 | 2012-02-16 | Theraclone Sciences, Inc. | Anti-hemagglutinin antibody compositions and methods of use thereof |
| CA3249351A1 (en) | 2010-08-31 | 2025-07-03 | Theraclone Sciences, Inc. | Neutralizing antibodies against human immunodeficiency viruses (HIV) |
| AU2012205301B2 (en) | 2011-01-14 | 2017-01-05 | Redwood Bioscience, Inc. | Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
| JP2014506580A (ja) | 2011-02-14 | 2014-03-17 | セラクローン サイエンシーズ， インコーポレイテッド | インフルエンザの治療および診断のための組成物および方法 |
| SG193402A1 (en) | 2011-03-15 | 2013-10-30 | Theraclone Sciences Inc | Compositions and methods for the therapy and diagnosis of influenza |
| US8822651B2 (en) | 2011-08-30 | 2014-09-02 | Theraclone Sciences, Inc. | Human rhinovirus (HRV) antibodies |
| RU2746407C1 (ru) | 2012-02-23 | 2021-04-13 | Стейдж Селл Терапеутикс Гмбх | Хроматографическое выделение клеток и других сложных биологических материалов |
| EP3578660A1 (en) * | 2012-07-05 | 2019-12-11 | F. Hoffmann-La Roche AG | Expression and secretion system |
| US20160194660A1 (en) * | 2012-12-21 | 2016-07-07 | Merck Sharp & Dohme Corp. | Expression vectors for recombinant protein production in mammalian cells |
| CN112142843B (zh) | 2013-12-24 | 2024-10-18 | 阿尔金克斯有限公司 | FcRn拮抗剂及使用方法 |
| WO2016004370A1 (en) * | 2014-07-03 | 2016-01-07 | Genentech, Inc. | Polypeptide expression systems |
| CN107922508B (zh) | 2015-06-12 | 2021-06-04 | 艾希奥美公司 | 用于产生嵌合多肽的方法和组合物 |
| TWI870335B (zh) | 2015-06-12 | 2025-01-21 | 美商宏觀基因股份有限公司 | 變異的嵌合4d5抗體及其與抗pd-1抗體聯合用於治療癌症的應用 |
| US11248238B2 (en) | 2015-10-22 | 2022-02-15 | Juno Therapeutics Gmbh | Methods, kits, agents and apparatuses for transduction |
| JP7194020B2 (ja) | 2015-10-22 | 2022-12-21 | ジュノ セラピューティクス ゲーエムベーハー | 細胞の培養方法ならびにそのためのキットおよび装置 |
| AU2017257504A1 (en) | 2016-04-26 | 2018-10-25 | R.P. Scherer Technologies, Llc | Antibody conjugates and methods of making and using the same |
| GB201617270D0 (en) | 2016-10-11 | 2016-11-23 | Argen-X N V And Fairjourney Biologics | Triple vector for expressing antibody molecules in full therapeutic format |
| JP7339160B2 (ja) | 2017-04-27 | 2023-09-05 | ジュノ セラピューティクス ゲーエムベーハー | オリゴマー粒子試薬およびその使用方法 |
| US12240875B2 (en) | 2017-12-08 | 2025-03-04 | argenx BV | Use of FCRN antagonists for treatment of generalized myasthenia gravis |
| US11795579B2 (en) | 2017-12-11 | 2023-10-24 | Abalone Bio, Inc. | Yeast display of proteins in the periplasmic space |
| CA3101462A1 (en) | 2018-06-08 | 2019-12-12 | Argenx Bvba | Compositions and methods for treating immune thrombocytopenia |
| EP3874024A1 (en) | 2018-10-31 | 2021-09-08 | Juno Therapeutics GmbH | Methods for selection and stimulation of cells and apparatus for same |
| CN114126647A (zh) | 2019-06-07 | 2022-03-01 | 阿尔金克斯有限公司 | 适用于皮下施用的FcRn抑制剂的药物制剂 |
| PH12022550141A1 (en) | 2019-07-19 | 2023-12-04 | Oncoresponse Inc | Immunomodulatory antibodies and methods of use thereof |
| BR112022013554A2 (pt) | 2020-01-08 | 2022-09-06 | argenx BV | Métodos para tratar distúrbios do pênfigo |
| US20240092926A1 (en) | 2021-01-20 | 2024-03-21 | Oncoresponse, Inc. | Immunomodulatory antibodies and uses thereof |
| CA3258000A1 (en) | 2022-06-15 | 2023-12-21 | argenx BV | FCRN/ANTIGEN BINDING MOLECULES AND METHODS OF USE |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4703004A (en) * | 1984-01-24 | 1987-10-27 | Immunex Corporation | Synthesis of protein with an identification peptide |
| US5807715A (en) * | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| DE4237113B4 (de) * | 1992-11-03 | 2006-10-12 | "Iba Gmbh" | Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins |
| US6627436B2 (en) * | 1997-10-31 | 2003-09-30 | Stratagene | Vector for gene expression in prokaryotic and eukaryotic systems |
| JP2002532066A (ja) * | 1998-11-16 | 2002-10-02 | ジェンウェイ バイオテック， インコーポレイテッド | 鳥類におけるポリヌクレオチドワクチンを用いる抗体の産生 |
| US7244592B2 (en) * | 2002-03-07 | 2007-07-17 | Dyax Corp. | Ligand screening and discovery |
| EP1588166A4 (en) * | 2003-01-09 | 2007-06-27 | Macrogenics Inc | VECTOR SYSTEM WITH DOUBLE EXPRESSION FOR EXPRESSING ANTIBODIES IN BACTERIAL AND MAMMAL CELLS |
-
2004
- 2004-01-08 EP EP04700895A patent/EP1588166A4/en not_active Withdrawn
- 2004-01-08 AU AU2004204462A patent/AU2004204462B2/en not_active Expired - Fee Related
- 2004-01-08 CA CA002513025A patent/CA2513025A1/en not_active Abandoned
- 2004-01-08 BR BR0406662-6A patent/BRPI0406662A/pt not_active IP Right Cessation
- 2004-01-08 JP JP2006500864A patent/JP4773947B2/ja not_active Expired - Fee Related
- 2004-01-08 US US10/753,309 patent/US7112439B2/en not_active Expired - Lifetime
- 2004-01-08 WO PCT/US2004/000462 patent/WO2004063343A2/en not_active Ceased
-
2005
- 2005-07-07 IL IL169604A patent/IL169604A/en not_active IP Right Cessation
-
2006
- 2006-08-10 US US11/503,399 patent/US7906327B2/en not_active Expired - Fee Related
-
2011
- 2011-01-26 US US13/014,422 patent/US20110136689A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006516195A5 (https=) | ||
| CN103827144B (zh) | 新的抗cxcr4抗体及其用于检测和诊断癌症的用途 | |
| JP5142265B2 (ja) | 抗モータリン抗体のパラトープ及びエピトープ | |
| US20190031770A1 (en) | Intercalated single-chain variable fragments | |
| KR20190134614A (ko) | B7-h3 항체, 이의 항원-결합 단편 및 이의 의학적 용도 | |
| JP2019504617A5 (https=) | ||
| JP2014528695A5 (https=) | ||
| JP2002508933A (ja) | 二官能分子 | |
| JP7411264B2 (ja) | 新規抗ｐａｄ２抗体 | |
| CN113150152A (zh) | 一种人源t细胞表面抑制性分子的特异性纳米抗体及其应用 | |
| JP2022531977A (ja) | 新規に設計された共局在化依存性タンパク質スイッチを使用する超特異的細胞標的化 | |
| JPH11127861A (ja) | Ｃ型肝炎ウイルス由来のセリンプロテアーゼに対する中和抗体部分ペプチド | |
| EP4324848A1 (en) | Human antibody targeting covid-19 virus | |
| KR101972899B1 (ko) | 소수성 테일 도메인이 제거된 먹장어 유래 VLRB 단백질과 C4bp 올리고머화 도메인이 연결된 융합 단백질 및 이의 용도 | |
| Rodenburg et al. | Production of a single chain anti-CEA antibody from the hybridoma cell line T84. 66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones | |
| CN118725100A (zh) | S100抗体及其用途 | |
| Kierny et al. | Generating recombinant antibodies against putative biomarkers of retinal injury | |
| CN119899272B (zh) | 抗ckmb抗体及其用途 | |
| CN119874904B (zh) | 抗NT-proBNP抗体及其用途 | |
| CN119874896B (zh) | 抗cTnI抗体及其用途 | |
| CN118255883B (zh) | 针对人视锥蛋白样蛋白1的单克隆抗体、抗体对和试剂盒及其应用 | |
| CN112079928B (zh) | 一种抗pd-l1的单克隆抗体 | |
| CN120173107A (zh) | 抗sST2抗体及其用途 | |
| CN120137027A (zh) | 抗胃泌素释放肽前体抗体及其用途 | |
| CN120137026A (zh) | 抗胃泌素释放肽前体抗体及其用途 |